1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. News
  7. Summary
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Toronto Stock Exchange  -  05/13 03:59:55 pm EDT
1.810 CAD   +9.70%
04/26OpSens Announces Health Canada Approval For Its New TAVR Guidewire
MT
04/26Opsens announces health canada approval for its new tavr guidewire
AQ
04/26Opsens Inc. Announces Health Canada Approval for Its New TAVR Guidewire
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OpSens Brief: Q1 EPS Basic and Diluted ($0.02) Vs Forecast EPS Normalized ($0.01) As Per Capital IQ and Last Year 0.01

01/13/2022 | 07:03am EDT


ę MT Newswires 2022
All news about OPSENS INC.
04/26OpSens Announces Health Canada Approval For Its New TAVR Guidewire
MT
04/26Opsens announces health canada approval for its new tavr guidewire
AQ
04/26Opsens Inc. Announces Health Canada Approval for Its New TAVR Guidewire
CI
04/13TRANSCRIPT : Opsens Inc., Q2 2022 Earnings Call, Apr 13, 2022
CI
04/13OPSENS : CEO Certification
PU
04/13OPSENS : CFO Certification
PU
04/13Opsens Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Februa..
CI
04/13OpSens Swings to Loss in Fiscal Q2 as Consolidated Sales Drop
MT
04/13OPSENS BRIEF : Net loss was $2.4 million in Q2 2022 compared with a net income of $41,000 ..
MT
04/13OPSENS BRIEF : Consolidated sales were $8.1 million in Q2 2022, compared with $8.8 million..
MT
More news
Analyst Recommendations on OPSENS INC.
More recommendations
Financials
Sales 2022 36,6 M 28,3 M 28,3 M
Net income 2022 -7,29 M -5,64 M -5,64 M
Net Debt 2022 - - -
P/E ratio 2022 -26,8x
Yield 2022 -
Capitalization 196 M 152 M 152 M
Capi. / Sales 2022 5,36x
Capi. / Sales 2023 3,61x
Nbr of Employees 163
Free-Float 95,0%
Chart OPSENS INC.
Duration : Period :
Opsens Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPSENS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 1,81 CAD
Average target price 4,22 CAD
Spread / Average Target 133%
EPS Revisions
Managers and Directors
Louis Laflamme President, Chief Executive Officer & Director
Robin Villeneuve Chief Financial Officer & Secretary
Alan W. Milinazzo Executive Chairman
Jean Lavigueur Independent Director
Denis L. Harrington Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPSENS INC.-41.61%152
THERMO FISHER SCIENTIFIC-18.86%211 945
DANAHER CORPORATION-24.26%178 394
INTUITIVE SURGICAL, INC.-37.74%80 295
SIEMENS HEALTHINEERS AG-17.38%63 485
EDWARDS LIFESCIENCES CORPORATION-24.70%60 652